Pacira Pharmaceuticals Inc. | Key People and Executives
David M. Stack
Chairman, Chief Executive & Operating Officer
Mark I. Froimson
Independent Director
Mark Kronenfeld
Independent Director
Gary W. Pace
Independent Director
Laura A. Brege
Independent Director
Paul J. Hastings
Lead Independent Director
Yvonne Greenstreet
Independent Director
Andreas Wicki
Independent Director
John P. Longenecker
Independent Director
David M. Stack
Chairman, Chief Executive & Operating Officer
Charles A. Reinhart
Chief Financial Officer
Richard E. Scranton
Chief Medical Officer
James B. Jones
Chief Medical Officer & Senior Vice President
Vladimir Kharitonov
Vice President-Research & Development
Kristen Marie Williams
Secretary & Chief Administrative Officer
Lauren Bullaro Riker
Vice President-Finance
David St. Peter
Vice President-Advanced Solutions & Customer Care
Robert J. Weiland
Chief Commercial Officer
Thomas Sluby
Vice President-Sales
Susan Mesco
Investor Relations Contact
Richard Kahr
Vice President-Human Resources
Mark I. Froimson
Independent Director
Mark Kronenfeld
Independent Director
Gary W. Pace
Independent Director
Laura A. Brege
Independent Director
Paul J. Hastings
Lead Independent Director
Yvonne L. Greenstreet
Independent Director
Andreas Wicki
Independent Director
John P. Longenecker
Independent Director
| Address |
5 Sylvan Way
Parsippany New Jersey 07054
United States
|
|
Employees
|
- |
| Website |
http://www.pacira.com |
| Updated |
07/08/2019 |
| Pacira Pharmaceuticals, Inc. is a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ. |
